Na Semax

Na Semax (N-Acetyl Semax Amidate) is a stabilized synthetic heptapeptide derived from the ACTH(4-10) fragment and modified with N-acetylation and C-terminal amidation to enhance metabolic stability. In laboratory and controlled experimental research, Na Semax is investigated for its interaction with neurotrophic and neurogenic signaling pathways under defined conditions. Structural modifications allow sustained evaluation of peptide-mediated transcriptional regulation and synaptic signaling mechanisms within central nervous system research frameworks.

In vitro systems and structured experimental investigations evaluate endpoints including brain-derived neurotrophic factor (BDNF) expression, TrkB receptor-associated signaling activity, and transcription factors linked to neuronal growth and plasticity such as NGF and GAP-43. Additional research explores CREB-related transcriptional responses, monoamine pathway indicators, redox homeostasis markers, oxidative stress biomarkers, and synaptic plasticity parameters under stress-model conditions.